Literature DB >> 26935067

A systematic molecular dynamics approach to the study of peptide Keap1-Nrf2 protein-protein interaction inhibitors and its application to p62 peptides.

Meng-Chen Lu1, Zhen-Wei Yuan, Yong-Lin Jiang, Zhi-Yun Chen, Qi-Dong You, Zheng-Yu Jiang.   

Abstract

Protein-protein interactions (PPIs) as drug targets have been gaining growing interest, though developing drug-like small molecule PPI inhibitors remains challenging. Peptide PPI inhibitors, which can provide informative data on the PPI interface, are good starting points to develop small molecule modulators. Computational methods combining molecular dynamics simulations and binding energy calculations could give both the structural and the energetic perspective of peptide PPI inhibitors. Herein, we set up a computational workflow to investigate Keap1-Nrf2 peptide PPI inhibitors and predict the activity of novel sequences. Furthermore, we applied this method to investigate p62 peptides as PPI inhibitors of Keap1-Nrf2 and explored the activity change induced by the phosphorylation of serine. Our results showed that because of the unfavorable solvation effects, the binding affinity of the phosphorylated p62 peptide is lower than the Nrf2 ETGE peptide. Our research results not only provide a useful method to investigate the Keap1-Nrf2 peptide inhibitors, but also give a good example to show how to incorporate computational methods into the study of peptide PPI inhibitors. Besides, applying this method to p62 peptides provides a detailed explanation for the expression of cytoprotective Nrf2 targets induced by p62 phosphorylation, which may benefit the further study of the crosstalk between the Keap1-Nrf2 pathway and p62-mediated selective autophagy.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26935067     DOI: 10.1039/c6mb00030d

Source DB:  PubMed          Journal:  Mol Biosyst        ISSN: 1742-2051


  6 in total

Review 1.  Small molecules inhibiting Keap1-Nrf2 protein-protein interactions: a novel approach to activate Nrf2 function.

Authors:  Chunlin Zhuang; Zhongli Wu; Chengguo Xing; Zhenyuan Miao
Journal:  Medchemcomm       Date:  2016-11-17       Impact factor: 3.597

2.  Investigation of the binding mode of a novel cruzain inhibitor by docking, molecular dynamics, ab initio and MM/PBSA calculations.

Authors:  Luan Carvalho Martins; Pedro Henrique Monteiro Torres; Renata Barbosa de Oliveira; Pedro Geraldo Pascutti; Elio A Cino; Rafaela Salgado Ferreira
Journal:  J Comput Aided Mol Des       Date:  2018-03-21       Impact factor: 3.686

3.  Polar Recognition Group Study of Keap1-Nrf2 Protein-Protein Interaction Inhibitors.

Authors:  Meng-Chen Lu; Shi-Jie Tan; Jian-Ai Ji; Zhi-Yun Chen; Zhen-Wei Yuan; Qi-Dong You; Zheng-Yu Jiang
Journal:  ACS Med Chem Lett       Date:  2016-07-05       Impact factor: 4.345

4.  Evaluation of peptide designing strategy against subunit reassociation in mucin 1: A steered molecular dynamics approach.

Authors:  J Lesitha Jeeva Kumari; R Jesu Jaya Sudan; C Sudandiradoss
Journal:  PLoS One       Date:  2017-08-17       Impact factor: 3.240

5.  Modified Peptide Inhibitors of the Keap1-Nrf2 Protein-Protein Interaction Incorporating Unnatural Amino Acids.

Authors:  Nikolaos D Georgakopoulos; Sandeep K Talapatra; Jemma Gatliff; Frank Kozielski; Geoff Wells
Journal:  Chembiochem       Date:  2018-07-18       Impact factor: 3.164

6.  Investigation of Molecular Details of Keap1-Nrf2 Inhibitors Using Molecular Dynamics and Umbrella Sampling Techniques.

Authors:  Ashwini Machhindra Londhe; Changdev Gorakshnath Gadhe; Sang Min Lim; Ae Nim Pae
Journal:  Molecules       Date:  2019-11-12       Impact factor: 4.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.